Sanofi India share price
You have to be logged in to add this to Watchlist.- ₹6,066.55(2.33%)May 14, 2025 15:28:10 PM IST
- NSE
- BSE
- Vol : 9.83K (NSE + BSE)Last 20 day avg : 18.96 K
Sanofi India is trading 2.33% upper at Rs 6,066.55 as compared to its last closing price. Sanofi India has been trading in the price range of 6,070.00 & 5,950.05. Sanofi India has given -3.15% in this year & 1.75% in the last 5 days. Sanofi India has TTM P/E ratio 44.95 as compared to the sector P/E of 24.51.There are 2 analysts who have initiated coverage on Sanofi India. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 91.30 Crores in its last quarter.Listed peers of Sanofi India include Jubilant Pharmova (0.20%), Alivus Life Sciences (4.01%), Sanofi India (2.33%).The Mutual Fund holding in Sanofi India was at 11.26% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Sanofi India was at 5.58% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 14, 2025, 01:38 PM UTC
- Dividend YieldHigher than industry2.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values15.66The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values32.62Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.60Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 9.74% from Rs 514.90 crore to Rs 469.20 crore, year-on-year
The company's profit declined by 33.70% year-on-year during the March quarter, dropping from Rs 137.70 crore to Rs 91.30 crore- The debt to equity of the company is higher than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 6,105.38
- R2
- 6,278.42
- R3
- 6,495.88
- S1
- 5,714.88
- S2
- 5,497.42
- S3
- 5,324.38
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Jubilant Pharmova | Neutral | 910.00 | 0.20 | 14,494.58 | 93.66 | 2.56 | 0.57 | 61.92 |
| Alivus Life Sciences | Bullish | 1,180.60 | 4.01 | 14,477.59 | 28.63 | 5.78 | 2.05 | 0.63 |
| Sanofi India | Moderately Bullish | 6,066.55 | 2.33 | 13,971.26 | 39.56 | 15.66 | 2.00 | 1.63 |
| Granules India | Neutral | 493.00 | 3.20 | 11,957.40 | 27.40 | 3.46 | 0.33 | 4.72 |
| Marksans Pharma | Neutral | 238.45 | 0.55 | 10,805.69 | 30.97 | 4.89 | 0.27 | 9.20 |
- Promoter(s) holds a high stake in the company at 60.40%
- FIIs are invested in this company
- FIIs holding has decreased by 0.06 percentage points from previous quarter
- Mutual Funds holding has increased by 0.21 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-14 | Quarterly Results |
| 2025-02-27 | Audited Results & Final Dividend |
| 2024-11-07 | Quarterly Results |
| 2024-07-26 | Quarterly Results |
| 2024-05-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE058A01010
- BSE Code500674
- NSE CodeSANOFI
Sanofi India is trading at 6066.55 as on Wed May 14 2025 09:58:10. This is 2.33% upper as compared to its previous closing price of 5928.60.
The market capitalization of Sanofi India is 13971.26 Cr as on Wed May 14 2025 09:58:10.
The average broker rating on Sanofi India is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Sanofi India is 7593.60 whereas the 52 wk low is 4145.90
Sanofi India can be analyzed on the following key metrics -
- TTM P/E: 44.95
- Sector P/E: 24.51
- Dividend Yield: 1.97%
- D/E ratio: 0.02
Sanofi India reported a net profit of 413.30 Cr in 2024.
The Mutual Fund Shareholding was 11.26% at the end of 31 Mar 2025.